|
GAB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53859999688189E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61450000035757E-08 |
| Normal-vs-Stage2 |
1.075290E-03 |
| Normal-vs-Stage3 |
1.139830E-02 |
| Normal-vs-Stage4 |
1.506260E-02 |
| Stage1-vs-Stage2 |
4.900600E-01 |
| Stage1-vs-Stage3 |
8.586000E-01 |
| Stage1-vs-Stage4 |
5.387400E-01 |
| Stage2-vs-Stage3 |
7.810800E-01 |
| Stage2-vs-Stage4 |
3.718400E-01 |
| Stage3-vs-Stage4 |
6.490000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.59839999516842E-08 |
| Normal-vs-AfricanAmerican |
4.83510000004461E-06 |
| Normal-vs-Asian |
1.198090E-04 |
| Caucasian-vs-AfricanAmerican |
7.798200E-01 |
| Caucasian-vs-Asian |
3.104400E-01 |
| AfricanAmerican-vs-Asian |
1.890200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39839999580005E-08 |
| Normal-vs-Female |
3.68250000000181E-05 |
| Male-vs-Female |
3.728200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.02649999999638E-05 |
| Normal-vs-Extreme_Weight |
9.24920029454768E-10 |
| Normal-vs-Obese |
4.630200E-04 |
| Normal-vs-Extreme_Obese |
2.956700E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.867800E-01 |
| Normal_Weight-vs-Obese |
2.685200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.376000E-01 |
| Extreme_Weight-vs-Obese |
3.600200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.015200E-01 |
| Obese-vs-Extreme_Obese |
7.392200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.638200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.02670000001748E-06 |
| Normal-vs-Age(61-80Yrs) |
1.03089999869965E-08 |
| Normal-vs-Age(81-100Yrs) |
2.27499999999603E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.494000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.626200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.923200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.317600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.278800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.544200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.28720000003702E-07 |
| Normal-VS-Type2 PRCC |
4.83350004465422E-09 |
| Normal-VS-KIRP CIMP |
3.570000E-01 |
| Normal-VS-Unclassified PRCC |
3.681300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.303800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.219200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.764600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.764200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.363900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.821600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.55059999787477E-08 |
| Normal-vs-N1 |
9.616500E-03 |
| Normal-vs-N2 |
9.968000E-04 |
| N0-vs-N1 |
5.996000E-01 |
| N0-vs-N2 |
3.577800E-01 |
| N1-vs-N2 |
1.279240E-01 |
|
|
